628 antibodies registered
Antibody ID ∧ ∨ | Antibody name ∧ ∨ | Epitope ID ∧ ∨ | Epitope name ∧ ∨ | Recognition region ∧ ∨ |
---|---|---|---|---|
AN0360 | NS24 | EP0314 | Neu5Ac(a2-3)Gal(b1-4)GlcNAc | Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0268 | NUH2 / NUH-2 | EP0095 | Disialyl I | Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-6)[Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)]Gal(1-4)GlcNAc(b1-)-R |
AN0111 | VIM-2 | EP0019 | VIM-2 | Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
AN0175 | NGR54 | EP0076 | 2-3 Sialylparagloboside | Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
AN0525 | MSG-1 | EP0053 | N-Acetyl GM3 | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Gc(a2-3)Gal(b1-4)Glc-R |
AN0525 | MSG-1 | EP0054 | N-Glycolyl GM3 | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Gc(a2-3)Gal(b1-4)Glc-R |
AN0525 | MSG-1 | EP0305 | Neu5Ac(a2-3)Gal(b1-4)Glc | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Gc(a2-3)Gal(b1-4)Glc-R |
AN0525 | MSG-1 | EP0313 | Neu5Gc(a2-3)Gal(b1-4)Glc | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Gc(a2-3)Gal(b1-4)Glc-R |
AN0372 | M2590 | EP0053 | N-Acetyl GM3 | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0372 | M2590 | EP0076 | 2-3 Sialylparagloboside | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0372 | M2590 | EP0305 | Neu5Ac(a2-3)Gal(b1-4)Glc | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0372 | M2590 | EP0314 | Neu5Ac(a2-3)Gal(b1-4)GlcNAc | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0815 | HYB4 | EP0053 | N-Acetyl GM3 | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0815 | HYB4 | EP0076 | 2-3 Sialylparagloboside | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0815 | HYB4 | EP0305 | Neu5Ac(a2-3)Gal(b1-4)Glc | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0815 | HYB4 | EP0314 | Neu5Ac(a2-3)Gal(b1-4)GlcNAc | Neu5Ac(a2-3)Gal(b1-4)Glc-R Neu5Ac(a2-3)Gal(b1-4)GlcNAc-R |
AN0371 | DH2 | EP0053 | N-Acetyl GM3 | Neu5Ac(a2-3)Gal(b1-4)Glc(b1-1)Cer |
AN0124 | GMR6 | EP0053 | N-Acetyl GM3 | Neu5Ac(a2-3)Gal(b1-4)Glc(b1-1)Cer |
AN0259 | FH7 / FH-7 | EP0040 | Disialyl Lewis a | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)][Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-)-R |
AN0563 | DMAb-21 | EP0096 | Disialyl Lewis c | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc-R Neu5Gc(a2-3)Gal(b1-3)[Neu5Gc(a2-6)]GlcNAc-R |
AN0564 | DMAb-22 | EP0096 | Disialyl Lewis c | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc-R Neu5Gc(a2-3)Gal(b1-3)[Neu5Gc(a2-6)]GlcNAc-R |
AN0277 | FH9 / FH-9 | EP0096 | Disialyl Lewis c | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
AN0347 | anti-Chol-1 alpha | EP0111 | GT1a alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
AN0435 | GGR41 / GGR-41 | EP0111 | GT1a alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
AN0347 | anti-Chol-1 alpha | EP0112 | GQ1b alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |